Pharmedic Pharmaceutical Medicinal Joint Stock Company
Pharmedic Pharmaceutical Medicinal Joint Stock Company, commonly referred to as Pharmedic, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2003, the company has made significant strides in the development and distribution of high-quality medicinal products across various regions in Vietnam and beyond. Pharmedic focuses on the research, production, and marketing of pharmaceuticals, including prescription medications and over-the-counter products. Its commitment to innovation and quality has positioned it as a trusted name in the market, with a diverse portfolio that caters to a wide range of therapeutic areas. Notable achievements include certifications from international quality standards, underscoring its dedication to excellence in healthcare. With a strong market presence, Pharmedic continues to enhance its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmedic Pharmaceutical Medicinal Joint Stock Company's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmedic Pharmaceutical Medicinal Joint Stock Company's reported carbon emissions
Pharmedic Pharmaceutical Medicinal Joint Stock Company, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that Pharmedic has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the pharmaceutical industry increasingly prioritises sustainability, Pharmedic's future commitments to carbon reduction and climate action will be crucial in aligning with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmedic Pharmaceutical Medicinal Joint Stock Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
